Pharma & Biotech
A trusted advisor to the world’s leading pharmaceutical and biotech companies
Consistently ranked in the top tier of legal directories, our lawyers are recognised experts at the forefront of legal developments in the pharmaceutical and biotech industry. As one of the most highly regarded life sciences law firms, Bristows is a trusted advisor to the world’s leading pharmaceutical and biotech companies.
How our pharmaceutical and biotech lawyers help
Pharmaceutical patent litigation
Our market-leading life sciences patent litigation team enforces and defends patents globally for blockbuster pharmaceutical and biotech products belonging to the largest and most successful life sciences companies. We coordinate cross-border litigation and develop winning strategies in complex, multi-jurisdictional cases, supported by regulatory and competition specialists, and provide launch-critical due diligence and freedom-to-operate (FTO) advice on the intellectual property behind drug products and associated technologies such as medical devices.
Life Sciences Regulatory
Our Life Sciences Regulatory team advises on the full spectrum of EU and UK regulatory matters across the biopharmaceutical and medical device sectors. We support clients throughout the product lifecycle, from early-stage development, clinical research and manufacturing through to market access, lifecycle management and post-market compliance. Our expertise in medicines spans regulatory exclusivities, orphan and paediatric medicines, promotional activities, and the regulatory framework governing manufacturing and supply chains. We are also at the forefront of advising on emerging and transformative technologies, including genomics, companion diagnostics, cell and gene therapies, digital health solutions and healthcare applications, helping clients navigate an increasingly complex and evolving regulatory landscape.
Transactions and commercial IP
Our transactional lawyers advise on strategically important corporate deals and commercial collaborations for the world’s most innovative pharmaceutical and biotech businesses. Our work spans high-value research and development agreements, strategic collaborations, acquisitions and disposals, financing transactions, licensing, clinical trials and manufacturing, supply and distribution arrangements, together with the associated competition law issues. Our Commercial IP team has particular expertise in cell and gene therapy, digital health, AI and data science projects.
Related topics:
Artificial intelligence | Cell & Gene Therapies | Devices & Healthtech | Digital health | Life sciences regulatory
Biotech Review of the Year - a snapshot of this year’s edition
Our biotech specialists Aida Tohala and Erik Müürsepp share the key legal, regulatory and commercial developments shaping pharma and biotech in this year’s Biotech Review of the Year.
Subscribe to our life sciences insights
Stay ahead of the legal, regulatory and patent developments shaping pharma and biotech. Subscribe to receive Bristows’ life sciences insights, event invitations and publications straight to your inbox.
Recognised as a leading life sciences law firm
Bristows is consistently ranked in the top tier of the legal directories for its life sciences work, including Band 1 for Life Sciences: IP/Patent Litigation in Chambers(opens in new tab) and Partners and Tier 1 for Life Sciences in The Legal 500.

